SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000814133-24-000064
Filing Date
2024-03-08
Accepted
2024-03-08 13:11:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 cccc324.txt SC 13G/A 2457
  Complete submission text file 0000814133-24-000064.txt   4163
Mailing Address 505 WAKARA WAY 3RD FLOOR SALT LAKE CITY UT 84108
Business Address 505 WAKARA WAY 3RD FLOOR SALT LAKE CITY UT 84108 8015330777
WASATCH ADVISORS LP (Filed by) CIK: 0000814133 (see all company filings)

IRS No.: 870319391 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Subject) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91763 | Film No.: 24733403
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)